KNSA
Kiniksa Pharmaceuticals International, plcData as of 2026 Q2 (06-30) · 13F snapshot
Summary
Kiniksa Pharmaceuticals International, plc (KNSA) is held as common stock by 6 tracked hedge-fund managers, with a combined reported value of ~$236.75M; the largest are Baker Bros. Advisors, Steven Cohen, Izzy Englander. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 1 added, 3 trimmed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Mixed
Common-stock holders61 also report options
Congress trades0
Price$75.73vs quarter-end+18.42%
Sectors0
This quarter's moves
Top holderBaker Bros. AdvisorsNew1
Added1
Trimmed / sold3
Common-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Value $181.28M0.9% of portfolio2,834,6432026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Baker Bros. Advisors | $181.28M | 0.9% | Hold |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $901.7K— of portfolio14,1002026 Q2
Value $364.5K— of portfolio5,7002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $901.7K | — | — |
| Ken GriffinPUT | $364.5K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.